Petmed Express Inc (NASDAQ:PETS)
| 44.75 Delayed Data As of Jun 19 |  -0.11 / -0.25%Today’s Change | 31.81 Today|||52-Week Range 57.80 | -1.65% Year-to-Date |
Latest PETS News | Press Releases
Today’s Trading
| Previous close | 44.86 |
| Today’s open | 44.65 |
| Day’s range | 43.69 - 44.83 |
| Volume | 571,900 |
| Average volume (3 months) | 541,994 |
| Market cap | $716.1M |
Data as of 4:00pm ET, 06/19/2018
Growth & Valuation
| Earnings growth (last year) | +55.56% |
| Earnings growth (this year) | +24.45% |
| Earnings growth (next 5 years) | +5.00% |
| Revenue growth (last year) | +9.88% |
| P/E ratio | 24.6 |
| Price/Sales | 3.12 |
| Price/Book | 6.19 |
Competitors
| ---- | ||
| DPLODiplomat Pharmacy In... | +0.81 | +3.10% |
| --Sau San Tong Holding... | -0.00 | -4.35% |
| SYBXSynlogic Inc | +0.23 | +2.45% |
Data as of 4:02pm ET, 06/19/2018
Financials
| Next reporting date | July 23, 2018 |
| EPS forecast (this quarter) | $0.64 |
| Annual revenue (last year) | $273.8M |
| Annual profit (last year) | $37.3M |
| Net profit margin | 13.62% |
Profile
Sector Retail Trade |
Industry Drugstore Chains |
President, Chief Executive Officer & Director Menderes Akdag |
Treasurer, Chief Financial & Accounting Officer Bruce S. Rosenbloom |
Corporate headquarters Delray Beach, Florida |
Forecasts
